Biotech Values

[floblu14]

UPDATE 1-U.S. FDA to review Mylan's generic Copaxone
Mon Sep 14, 2009 7:38am EDT

Teva shares fall 3.8 percent in U.S.

Momenta Pharmaceuticals Inc (MNTA.O) said in July 2008 that the U.S. Food and Drug Administration had accepted its generic Copaxone application for review. Teva sued Momenta and partner Novartis AG (NOVN.VX) the following month for patent infringement.

http://www.reuters.com/article/rbssHealthcareNews/idUSN1449708220090914